The healthcare information and digital clinical decision support systems provider has released a trading update. The Covid 19 pandemic is something of a double-edged sword for DXS. Revenues are holding up well, marginally up on those for the same period in the previous financial year (£1.65m), and the Company continues to trade profitably. This is against a backdrop of a mentally and financially stretched core client base of General Practitioners (GPs).
